Please login to the form below

Not currently logged in

online physician communities

This page shows the latest online physician communities news and features for those working in and with pharma, biotech and healthcare.

Sermo reaches 150,000 members after global expansion drive

Sermo reaches 150,000 members after global expansion drive

Online physician community now has doors open in more than 150 new countries. ... The US-based online physician community says its expansion means doctors from all seven continents can now collaborate to crowdsource medical information and rate medicines.

Latest news

More from news
Approximately 11 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • How to work with global online doctor networks How to work with global online doctor networks

    This supplement is sponsored by Networks in Health, the unique global alliance of trusted online physician communities with more than two million physician members worldwide (and 760, 000 in Europe). ... Dr Tim Ringrose is CEO of Networks in Health, the

  • Benchmarking product launches via online networks Benchmarking product launches via online networks

    Networks in Health - a unique international alliance of online physician networks with more than two million members worldwide, including the likes of (UK), Egora (France), coliquio (Germany) &Medcenter ... To share their knowledge of how

  • The rise of online physician communities in Europe The rise of online physician communities in Europe

     . A DIGITAL REVOLUTION: The use of authenticated online physician communities has been increasing exponentially across Europe in recent years. ... To share their vast knowledge and experience of European online physician communities, Networks in Health

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • How should pharma engage with GPs on new drugs?

    What influences a GP's prescribing intentions and how should pharma respond to their changing needs? We asked member and GP Partner Dr Una Duffy for her opinion. Read the full article here: .

  • Is pharma’s marketing model broken?

    by Jenny Cowderoy, MD Communications, M3 (EU). In a recent Digital Handbook article, I said that digital is not a marketing channel: It is a whole new version of the real world, and you can choose to replicate your existing business model and

  • How can pharma realise the power of digital?

    Firstly, by making it owned and driven by the most senior leadership team in the business. New data from M3 Global Research shows that doctors want to work with pharma and they have embraced the digital revolution: 80% of doctors across the EU want

  • Is the pharma industry bad?

    Surveys of doctors and the public suggest not. The pharma industry has always had its critics and Ben Goldacre discusses the key criticisms levelled against it in his book,  Bad Pharma, where he examines lack of transparency over data, and payments

  • M3 and partners win Digital Sales Aid Award

    Wins for campaign to overcome limited doctor engagement with pharma-owned websites. M3 - the global provider of technology services in healthcare – has scooped the PM Society's 'Digital Sales Aid Award', for a campaign run in partnership with

More from PMHub
Approximately 1 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...